NEXT — Next Biometrics ASA Income Statement
0.000.00%
Last trade - 00:00
- NOK884.21m
- NOK818.40m
- NOK34.38m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 84.4 | 58.1 | 50.8 | 48.3 | 34.4 |
Cost of Revenue | |||||
Gross Profit | 20.6 | 8.75 | 8.97 | 14.8 | 7.38 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 249 | 163 | 109 | 96.4 | 101 |
Operating Profit | -165 | -105 | -58.3 | -48.1 | -66.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -164 | -105 | -58.4 | -46.4 | -65.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -166 | -102 | -60 | -46.3 | -65.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -166 | -102 | -60 | -46.3 | -65.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -166 | -102 | -60 | -46.3 | -65.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.81 | -1.52 | -0.672 | -0.505 | -0.683 |
Dividends per Share |